Latest News and Insights
Please Visit Often to Stay Current
Aided by Cure Ventures’ diligent and rigorous approach to company building, we’re pioneering the platform technology of hyperacute rejection to fight cancer and I’m excited to say our lead therapy has shown proof-of-concept in in vitro and in vivo models. With the help of Cure’s seed funding and active collaboration, we continue to generate the data...
Don't Miss a Beat
Subscribe to Our Email List